Nga M.

Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor

Rajesh Kumar, Michael J. Karmilowicz, Dylan Burke et al. · Nature Catalysis · 2021 · 136 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Process Research and Development of an NK-1 Receptor Antagonist. Enantioselective Trifluoromethyl Addition to a Ketone in the Preparation of a Chiral Isochroman

Stéphane Caron, Nga M., Janice E. Sieser et al. · Organic Process Research & Development · 2007 · 95 citations

Pharmacy, Chemistry, Medicinal Chemistry +13

A practical, efficient, and rapid method for the oxidation of electron deficient pyridines using trifluoroacetic anhydride and hydrogen peroxide–urea complex

Stéphane Caron, Nga M., Janice E. Sieser · Tetrahedron Letters · 2000 · 81 citations

Natural Sciences, Chemistry, Organic Chemistry +7

Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin

Paul Bowles, Steven J. Brenek, Stéphane Caron et al. · Organic Process Research & Development · 2013 · 67 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Application of Quantitative ¹⁹F and ¹H NMR for Reaction Monitoring and In Situ Yield Determinations for an Early Stage Pharmaceutical Candidate

Nga M., Mark A. Olivier, John J. Salisbury et al. · Analytical Chemistry · 2011 · 50 citations

Natural Sciences, Chemistry, Pharmaceutical Analysis +13